Important

Research Use Notice

All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Do not administer these products to humans or animals.

Product Documentation

Details, specifications, and documents

Description

KPV 10 mg: research material

Buy KPV 10 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.

KPV is the tripeptide lysine-proline-valine, corresponding to the C-terminal three-residue sequence of alpha-melanocyte-stimulating hormone (alpha-MSH). It is studied in peptide transport and inflammatory-signaling models.

Choose the material and presentation

This 10 mg product is single-compound KPV. It differs from full-length alpha-MSH and from the KLOW and Tri-Heal blends, whose total mass includes other ingredients. Compare the individual compound amounts when a study calls for KPV alone.

The labeled mass is not a concentration or an experimental dose. Match the peptide identity and any specified terminal chemistry or salt form to your method. The three-letter name identifies the residue sequence; the applicable material records provide the supplied-product details.

KPV uptake and inflammatory signaling

Intestinal epithelial and immune-cell models

Dalmasso and colleagues studied KPV in intestinal epithelial cell lines and Jurkat T cells. They used uptake experiments alongside NF-kappaB reporter, protein and cytokine assays. Their results linked the PepT1 di/tripeptide transporter to cellular uptake and lower activation of selected NF-kappaB and MAP kinase pathways.

The study also examined two chemically induced mouse-colitis models. These experiments help distinguish transport, pathway measurements and tissue-level outcomes. They do not establish a human treatment effect or a dosing schedule for this research material.

Read the original PepT1 study

Mechanism depends on the cell system

In a separate study of immortalized human bronchial epithelial cells, Land compared KPV with gamma-MSH. KPV reduced nuclear entry of the NF-kappaB component p65RelA; gamma-MSH’s response instead required the melanocortin-3 receptor, MC3R, in that model. The work measured reporter activity and inflammatory signaling, including IL-8 and eotaxin secretion.

The comparison shows why a relationship to melanocortin peptides does not imply identical receptor dependence. Record the cell type, stimulus, uptake conditions and measured endpoint when assessing a KPV experiment.

Read the original airway-cell study

Product records and batch reports

Review available lot reports and product files in the product documentation section. Check the product and lot identifiers, then read identity, chromatographic purity and measured content as separate results.

Use the applicable material instructions for handling and storage. A general paper about KPV, or another supplier’s preparation instructions, does not verify this batch’s chemical form, stability or suitability for a particular assay.

Additional information

Purity

≥99%

Sequence

Lys-Pro-Val

Molecular Formula

C16H30N4O4 (reference molecule; excludes counterions and fillers)

Molecular Weight

342.43 g/mol (reference molecule; excludes counterions and fillers)

Applications

In-vitro assay research, compound characterization, analytical method development

Synthesis

Solid-phase synthesis

Solubility

Soluble in water or 1% acetic acid

Stability & Storage

Stable for up to 24 months at -20°C.

Appearance

White lyophilized powder

Shipping Conditions

Shipped at ambient temperature; once received, store at -20°C

Regulatory/Compliance

Manufactured in a facility that adheres to cGMP guidelines

Safety Information

Refer to provided MSDS

COA & Documents

Independent lot testing

KPV 10mg Certificate of Analysis

This product has featured batch-specific third-party laboratory documentation. The Pure Lab Peptides summary presents selected source-report fields in a consistent format; the linked original laboratory report controls if any information differs.

Lot number
57460
Report number
IF-824-QSA-TR006-BTL2649-13
Date tested
March 18, 2026
Reported purity
99.5%
Labeled content
10 mg
DOWNLOADABLE RESOURCES

Product documents

Product information and laboratory resources. For lot-specific results, use the COA above.

PDF

Product & packaging information

Labeled amount, physical form and packaging for KPV 10mg.

Revision 0.4 · 2026-10-05Download PDF
PDF

Laboratory handling guide

General guidance for applicable lyophilized research materials. Not a product-specific SDS.

Revision 1.0 · 2026-09-22Download PDF
General guides & resources

Need Assistance?

Questions about product documentation?

Contact our support team for help with product records, lot information, orders or certificate verification.

Contact Support